Nucs AI Expands Leadership Team to Accelerate AI-Driven Precision in Prostate Cancer Care
New Chief of Staff, Medical Director and VP of Product join executive team to unite clinical expertise, AI innovation, and...
Clinical Trial
Luminopia Awarded on TIME’s List of the World’s Top HealthTech Companies 2025
The company was recognized by TIME for reimagining pediatric treatment for lazy eye, the leading cause of vision loss in...
Best Practices to Ensure a Smooth CRO Handoff and Data Continuity, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how to navigate contract research organization (CRO) transitions with a functional service provider (FSP) team...
ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks
In this free webinar, get the inside scoop on the new ICH GCP E6(R3) guidelines and why they matter. Attendees...
TransCelerate Advances Industrywide Shift To Digital Protocols
Global stakeholders convene at TransCelerate's annual Digital Data Flow events; momentum builds through regulatory readiness, industry adoption, AI enablement, and...
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform
Under the new entitlement agreement, Hoth Therapeutics secures annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure, enabling...
Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections
Belhaven's Investigational New Drug (IND) Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 8,...
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter
SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology...
PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists
TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology...
Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device
40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, the flagship journal...
NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model
Accelerates Warrant Expirations and POSITIVE Communications ExtensionTORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)...
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to...
Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
MORRISVILLE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today...
Evaxion expands AI-Immunology™ platform with automated vaccine design module
New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior...
Prenetics’ IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging
Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with...
Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with...
A DEA Bad Penny Keeps Turning Up: Ex-DEA Official Matthew Strait Resurfaces in the Online Pharmacy Lobby
The DEA Regulatory Revolving Door Spins AgainAfter years of blocking FDA approved cannabis research for Huntington's and Multiple Sclerosis, former...
DEA Tribunal System Collapses: What MMJ BioPharma’s Lawsuit Means for the Marijuana Rescheduling
Constitutional Earthquake: The End of the DEA's In-House CourtDOJ's reversal on administrative law judge protections vindicates MMJ BioPharma's constitutional challenge...
Oracle Health Powers Rural Health Innovation and Transformation
Provides comprehensive, AI-powered solutions to help states deliver sustainable, high-quality healthcare in rural communities Offers recommendations to states seeking to...
Suvoda Expands Clinical Trial Patient Travel Access Across the EU With Bolt Business Partnership
CONSHOHOCKEN, Pa., Oct. 7, 2025 /PRNewswire/ -- Suvoda (recently merged with Greenphire), a global clinical trial technology company specializing in software...